background
venoven
extracorpor
membran
oxygen
vvecmo
one
ultim
treatment
acut
respiratori
failur
howev
effect
ecmo
patient
novel
coronaviru
diseas
unknown
case
present
woman
passeng
cruis
ship
test
posit
sever
acut
respiratori
syndrom
coronaviru
quarantin
board
use
throat
swab
three
day
admiss
condit
deterior
subsequ
intub
day
vvecmo
introduc
lopinavirritonavir
given
continu
renal
replac
therapi
also
introduc
day
chest
radiographi
lung
complianc
improv
wean
ecmo
day
conclus
treatment
sever
pneumonia
ecmo
recogn
lung
plastic
consid
time
ecmo
introduct
interstiti
biomark
japan
central
ecmo
patient
suffici
thu
suggest
nationwid
central
research
respond
crisi
caus
novel
coronaviru
diseas
first
report
wuhan
china
spread
worldwid
japan
sinc
cruis
ship
dock
yokohama
number
domest
patient
gradual
increas
among
chines
case
preval
sever
pneumonia
mortal
rate
venoven
extracorpor
membran
oxygen
vvecmo
one
ultim
treatment
acut
respiratori
failur
howev
effect
ecmo
patient
unknown
report
describ
treatment
sever
pneumonia
first
case
japan
treat
vvecmo
yearold
nativ
hawaiian
woman
passeng
cruis
ship
test
posit
sever
acut
respiratori
syndrom
coronaviru
quarantin
board
use
throat
swab
transport
emerg
room
fever
dyspnea
day
consid
day
case
timelin
histori
chronic
kidney
diseas
stage
diabet
also
class
obes
bodi
mass
index
kgm
vital
sign
emerg
room
follow
patient
alert
respiratori
rate
breathsmin
oxygen
satur
oxygen
mask
lmin
heart
rate
bpm
blood
pressur
mmhg
physic
examin
reveal
bilater
wheez
laboratori
test
result
admiss
shown
tabl
chest
radiographi
comput
tomographi
show
bilater
groundglass
opac
consolid
fig
day
arriv
condit
rel
stabl
diagnos
mild
pneumonia
caus
subsequ
admit
isol
room
respiratori
ward
admiss
oxygen
therapi
maintain
g
cefepim
mg
clindamycin
phosphat
given
everi
day
day
pneumonia
worsen
fig
day
led
acut
respiratori
distress
syndrom
ard
transfer
gener
intens
care
unit
intub
fig
lopinavirritonavir
approv
ethic
committe
treatment
given
week
three
day
later
serum
creatin
level
increas
urin
output
almost
zero
metabol
acidosi
caus
excess
spontan
breath
tabl
although
cardiac
function
normal
norepinephrin
need
maintain
blood
pressur
determin
reason
hypoxia
cardiogen
congest
acut
kidney
injuri
chronic
kidney
diseas
sever
ard
septic
shock
develop
patient
transfer
ecmo
unit
decid
establish
vvecmo
right
intern
jugular
vein
cannul
heparinco
cannula
blood
access
right
femor
vein
cannul
heparinco
cannula
blood
return
procedur
complet
safe
complic
occur
oxygen
stabl
start
continu
renal
replac
therapi
crrt
earli
nutrit
rehabilit
undertaken
ecmo
introduct
day
chest
radiographi
lung
complianc
improv
ecmo
discontinu
day
durat
ecmo
support
day
respir
remov
tracheostomi
day
u
ntil
drug
confirm
safe
effect
sever
pneumonia
world
health
organ
interim
guidelin
made
recommend
treatment
ard
set
includ
refer
patient
refractori
respiratori
failur
expert
center
capabl
provid
vvecmo
yokohama
citi
univers
medic
center
advanc
critic
care
emerg
center
referr
center
adult
patient
requir
ecmo
yokohama
japan
member
extracorpor
life
support
organ
role
ecmo
manag
unclear
point
howev
ecmo
one
treatment
option
sever
ard
extracorpor
membran
oxygen
still
invas
signific
potenti
complic
high
resourc
cost
could
present
econom
challeng
health
system
clinic
judgment
need
decid
whether
ecmo
effect
accompani
understand
risktobenefit
ratio
therefor
import
predict
case
ecmo
could
effect
treatment
method
present
case
patient
wean
ecmo
follow
reason
first
time
ecmo
introduct
might
adequ
venoven
ecmo
introduc
day
intub
respiratori
ecmo
surviv
predict
score
also
point
expect
surviv
addit
level
biomark
kreb
von
den
surfact
proteind
spd
indic
lung
injuri
increas
although
report
pneumonia
caus
progress
slowli
like
sever
time
lung
plastic
maintain
ecmo
introduct
might
prevent
subsequ
lung
injuri
fact
spd
level
still
increas
day
tabl
second
recognit
treatment
caus
worsen
oxygen
might
appropri
one
caus
worsen
oxygen
might
overvolum
due
acut
kidney
injuri
chronic
kidney
diseas
howev
believ
caus
worsen
oxygen
overvolum
also
aggrav
ard
pneumonia
accord
comput
tomographi
pneumonia
progress
day
radiologist
suggest
inflammatori
find
stronger
pulmonari
congest
therefor
introduc
ecmo
stabil
oxygen
rest
lung
remov
excess
water
improv
metabol
acidosi
crrt
third
may
reduc
inflammatori
substanc
administ
lopinavirritonavir
control
viru
improv
inflamm
viru
detect
tracheal
sputum
ecmo
withdraw
anoth
possibl
remov
inflammatori
substanc
crrt
howev
exam
inflammatori
cytokin
cinterferon
addit
research
need
best
knowledg
first
report
vvecmo
use
treat
sever
pneumonia
japan
flu
pandem
effect
ecmo
establish
region
nation
coordin
ecmo
referr
center
dedic
interhospit
retriev
team
howev
japan
mani
hospit
ecmo
capabl
low
case
volum
central
adequ
compar
uk
sweden
conclus
treat
sever
pneumonia
ecmo
recogn
lung
plastic
appropri
implement
ecmo
follow
extracorpor
life
support
organ
guidelin
present
given
increas
concern
pandem
suggest
countri
japan
expedit
central
ecmo
collect
data
research
undertak
investig
respond
crisi
caus
